Christian Lohrmann1, Etelka Foeldi, Oliver Speck, Mathias Langer. 1. Department of Radiology, Division of Diagnostic Radiology, University Hospital of Freiburg, Hugstetter Strasse 55, D-79106, Freiburg, Germany. lohrmann@mrs1.ukl.uni-freiburg.de
Abstract
OBJECTIVE: The objective of our study was to evaluate the feasibility of high-resolution MR lymphangiography with intracutaneous injection of gadodiamide, a commercially available, nonionic, extracellular paramagnetic contrast agent, for the visualization of lymphatic vessels in patients with primary and secondary lymphedema. CONCLUSION: High-resolution MR lymphangiography is safe, is technically feasible, and has the potential to become a diagnostic imaging tool for patients with lymphedema.
OBJECTIVE: The objective of our study was to evaluate the feasibility of high-resolution MR lymphangiography with intracutaneous injection of gadodiamide, a commercially available, nonionic, extracellular paramagnetic contrast agent, for the visualization of lymphatic vessels in patients with primary and secondary lymphedema. CONCLUSION: High-resolution MR lymphangiography is safe, is technically feasible, and has the potential to become a diagnostic imaging tool for patients with lymphedema.
Authors: Maria Antonietta Mazzei; Francesco Gentili; Francesco Giuseppe Mazzei; Paolo Gennaro; Duccio Guerrieri; Andrea Nigri; Guido Gabriele; Elisabetta Weber; Alfonso Fausto; Giuseppe Botta; Luca Volterrani Journal: Radiol Med Date: 2017-08-02 Impact factor: 3.469
Authors: Mike Notohamiprodjo; Ruediger G H Baumeister; Tobias F Jakobs; Kerstin U Bauner; Holger F Boehm; Annie Horng; Maximilian F Reiser; Christian Glaser; Karin A Herrmann Journal: Eur Radiol Date: 2009-06-06 Impact factor: 5.315
Authors: Ruchi Sharma; Juliet A Wendt; John C Rasmussen; Kristen E Adams; Milton V Marshall; Eva M Sevick-Muraca Journal: Ann N Y Acad Sci Date: 2008 Impact factor: 5.691
Authors: Geunwon Kim; Martin P Smith; Kevin J Donohoe; Anna Rose Johnson; Dhruv Singhal; Leo L Tsai Journal: Eur Radiol Date: 2020-03-27 Impact factor: 5.315